Advertisement

Topics

End-to-end drug & diagnostic development support for a new immuno-oncology agent: A case study

05:44 EDT 22 Jun 2017 | BioPharmaDive

Immuno-oncology drug development is inherently complex and requires special considerations across the entire spectrum.

Original Article: End-to-end drug & diagnostic development support for a new immuno-oncology agent: A case study

NEXT ARTICLE

More From BioPortfolio on "End-to-end drug & diagnostic development support for a new immuno-oncology agent: A case study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...